Aurinia Pharmaceuticals Inc.
AUPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001600620
In the last 90 days, Aurinia Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 282 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Aurinia Pharmaceuticals Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 178
- −12 vs. Q4 2023
- Shares held
- 55.8M
- +1.80M (+3.3%) vs. Q4 2023
- Total value
- $280.8M
- −$204.4M (−42.1%) vs. Q4 2023
- New holders
- 27
- 46 more added
- Sold out
- 39
- 63 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AUPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 282 | $1.34B |
| Q1 2026 | 260 | $1.10B |
| Q4 2025 | 256 | $1.15B |
| Q3 2025 | 242 | $729.8M |
| Q2 2025 | 219 | $497.1M |
| Q1 2025 | 214 | $504.1M |
| Q4 2024 | 200 | $525.4M |
| Q3 2024 | 183 | $428.9M |
| Q2 2024 | 171 | $319.9M |
| Q1 2024 | 178 | $280.8M |
| Q4 2023 | 191 | $485.4M |
| Q3 2023 | 198 | $395.2M |
| Q2 2023 | 200 | $487.5M |
| Q1 2023 | 186 | $553.5M |
| Q4 2022 | 192 | $223.1M |
| Q3 2022 | 189 | $420.5M |
| Q2 2022 | 199 | $509.9M |
| Q1 2022 | 184 | $532.9M |
| Q4 2021 | 191 | $895.1M |
| Q3 2021 | 167 | $966.8M |
| Q2 2021 | 167 | $640.9M |
| Q1 2021 | 170 | $682.5M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Aurinia Pharmaceuticals Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cetera Advisor Networks LLC | 0 | $0 | 0.00% | −10,279−100.0% | Sold out |
| Patriot Financial Group Insurance Agency, LLC | 0 | $0 | 0.00% | −10,225−100.0% | Sold out |
| Eagle Asset Management Inc | 0 | $0 | 0.00% | −10,210−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −10,209−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −8,641−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −5,163−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −4,600−100.0% | Sold out |
| Vermillion & White Wealth Management Group, LLC | 0 | $0 | 0.00% | −3,300−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −1,560−100.0% | Sold out |
| RFP Financial Group LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −350−100.0% | Sold out |
| CVA Family Office, LLC | 0 | $0 | 0.00% | −139−100.0% | Sold out |
| Vima LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| TD Waterhouse Canada Inc. | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −55−100.0% | Sold out |
| NinePointTwo Capital | – | – | – | – | Not filed |